Industry

In Other News

• Glycated Hemoglobin Tests See Increasing Use

• Siemens Renews Contract with Premier Purchasing Partners

• Selective Automation Vital for Clinical Labs to Remain Competitive

• Olympus Signs Licensing Agreements with Omnyx

• Merck Outbids Rivals in Millipore Takeover

• Biocartis Acquires Philips Technology Platform for Automated DNA/RNA Molecular Diagnostic Testing

• Partnership to Create a Genetic Analysis Service and European Demonstration Facility

• Testing Increasingly Decisive in Physician Diagnosis

• New Chips with Rare Variants to Drive Growth in SNP Market

• "Norway-Type” MRSA Strategy in U.S. Likely to Bolster Diagnostics

• OraSure and Roche in Worldwide Commercialization Agreement for Drugs of Abuse Assays

• AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments

• Mammography Reporting Software Increases Identification of High-Risk Breast Cancer Patients

• Qiagen Acquires ESE and Expands Applied Testing

• Bladder Cancer Detection Technology Uses Fluorescence Cystoscopy

• 2010 Arab Health Exhibition and Congress Set to Open

• Quidel Acquires Diagnostic Hybrids for US$130 Million

• Qiagen and WuXi AppTec Partner for Molecular Biomarkers

• A Diagnostic Test Is Being Developed for Preeclampsia

• Molecular Diagnostics Company Predictive Biosciences Buys OncoDiagnostic Laboratory

• Cardiac Marker POC Tests Now Widely Used in Hospitals

• Clarient's AGI Acquisition Nets Diagnostic, Prognostic, and Theranostic Tests

• Bel-Art Products Acquires Magic Touch Icewares International